[Activated recombinant factor VII for bleeding after a kidney transplant].
Vidal
M A
MA
Sebastianes
C
C
Eizaga
R
R
Martínez
E
E
Torres
L M
LM
D002545:Brain Ischemia / Q000150:complications; D002544:Cerebral Infarction / Q000150:complications; D017707:Erythrocyte Transfusion; D005167:Factor VII / Q000627:therapeutic use*; D015942:Factor VIIa; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000601:surgery; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D010438:Peptic Ulcer Hemorrhage / Q000150:complications; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects; D017713:Platelet Transfusion; D019106:Postoperative Hemorrhage / Q000188:drug therapy*; D011300:Preoperative Care; D011994:Recombinant Proteins / Q000627:therapeutic use; D013276:Stomach Ulcer / Q000150:complications; D014927:Wolff-Parkinson-White Syndrome / Q000150:complications
D010975:Platelet Aggregation Inhibitors; D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa